These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23974417)

  • 21. Extemporaneous Compounding: Selective Pharmacists with Separate Skill.
    Mohiuddin AK
    Innov Pharm; 2019; 10(4):. PubMed ID: 34007590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basics of compounding for the implementation of United States pharmaceopeia chapter 797 pharmaceutical compounding-sterile preparations, part 1.
    Allen LV; Okeke C
    Int J Pharm Compd; 2007; 11(3):230-6. PubMed ID: 23996026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(5):440-3. PubMed ID: 23969870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sterile Compounding Pharmacies: States That Do and Do Not Require Compliance With USP <797> Versus FDA 483s.
    Wilson M
    Ther Innov Regul Sci; 2016 May; 50(3):279-303. PubMed ID: 30227076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basics of compounding: United States pharmacapeia general chapter 797 pharmaceutical compounding-sterile preparations, part 10: first revision: the main changes, events, and rationale.
    Okeke CC; Newton DW; Kastango ES; Allen LV
    Int J Pharm Compd; 2008; 12(6):530-6. PubMed ID: 23969931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(2):136-44. PubMed ID: 23969607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compounding pharmacies: who is in charge?
    Pergolizzi JV; Labhsetwar S; LeQuang JA
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
    Allen LV
    Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2010; 14(2):142-9. PubMed ID: 23965426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction to hospital compounding.
    McElhiney LF
    Int J Pharm Compd; 2006; 10(4):245-50. PubMed ID: 23974255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued).
    Okeke CC; Allen LV
    Int J Pharm Compd; 2009; 13(4):322-9. PubMed ID: 23966523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 35. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparation, part 3: risk levels.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(5):404-10. PubMed ID: 23969522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putting the science back into the "art and science" of compounding.
    Kastango ES
    Int J Pharm Compd; 2006; 10(4):263-8. PubMed ID: 23974257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy.
    Moehring RW; Lewis SS; Isaacs PJ; Schell WA; Thomann WR; Althaus MM; Hazen KC; Dicks KV; Lipuma JJ; Chen LF; Sexton DJ
    JAMA Intern Med; 2014 Apr; 174(4):606-12. PubMed ID: 24493147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tips for cleanroom construction and renovation.
    Mixon W; Huffman L
    Int J Pharm Compd; 2009; 13(2):100-4. PubMed ID: 23970002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.